Plasmodium falciparum protein target

Plasmodium falciparum protein targets refers to essential and druggable proteins in the malaria-causing parasite P. falciparum that are being investigated as points of intervention for antimalarial drug development. These proteins span a wide range of molecular functions including enzymes (such as kinases, proteases, and metabolic pathway components), transporters, and other parasite-specific proteins essential for survival, proliferation, or infectivity. Drug discovery strategies focus on identifying proteins with essential roles in parasite biology that are sufficiently different from human proteins to minimize toxicity, aiming to overcome existing antimalarial drug resistance and address all stages of the parasite lifecycle[1][3][4][5][10]. The category is not a single protein but an umbrella term used in research and pharmaceutical development for new antimalarial agents.

Other names

P. falciparum protein drug targetsMalaria protein targetsPlasmodium falciparum antimalarial targetsEssential Plasmodium falciparum proteins

Enzyme inhibition (e.g., blockade of biosynthetic enzymes); Ion transport inhibition (e.g., blocking sodium ATPase); Protein synthesis inhibition; Redox disruption; Inhibition of cell cycle or cell division; Inhibiting nutrient uptake